Literature DB >> 12499661

Time- and dose-dependent effect of fosfomycin on suppression of infection-induced endotoxin shock in mice.

Kiichiro Kawaguchi1, Ryoichi Hasunuma, Sei-ichi Kikuchi, Roland Ryll, Keiko Morikawa, Yoshio Kumazawa.   

Abstract

Therapeutic effects of fosfomycin (FOF) and imipenem (IPM) were investigated in a novel model for endotoxin shock that was caused by intraperitoneal (i.p.) infection with 10(8) colony forming units of attenuated Salmonella typhimurium. Acute lethal shock was observed in BALB/c and ddY but not in lipopolysaccharide (LPS)-nonresponder BALB/lps(d) mice. Effects of FOF, but not its enantiomer, and IPM were dose- and time-dependent, since therapeutic efficacy was demonstrated in mice injected i.p. or orally at doses of more than 20 mg/kg 15 min before or 1 h after infection. Treatment with FOF 1 h postinfection (p.i.) resulted in significant decreases in bacterial numbers in spleen and liver, suggesting that the antimicrobial activity of FOF seems to closely correlate to suppression of infection-induced lethal shock. Regarding coagulation systems, FOF inhibited increase in the prothrombin time but upregulated fibrinogen concentration. Plasma levels of LPS released from bacilli were significantly higher in FOF- than IPM-treated mice and infection controls, but both antibiotics showed similar efficacy in protection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12499661     DOI: 10.1248/bpb.25.1658

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  3 in total

1.  The small RNA chaperone Hfq is required for the virulence of Yersinia pseudotuberculosis.

Authors:  Chelsea A Schiano; Lauren E Bellows; Wyndham W Lathem
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

2.  Immunomodulatory effects of fosfomycin in experimental human endotoxemia.

Authors:  Robert Sauermann; Claudia Marsik; Ilka Steiner; Katja Seir; Tuende Cvitko; Markus Zeitlinger; Oswald Wagner; Christian Joukhadar
Journal:  Antimicrob Agents Chemother       Date:  2007-03-12       Impact factor: 5.191

3.  Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections.

Authors:  Alexandro Rodríguez-Rojas; María D Maciá; Alejandro Couce; Cristina Gómez; Alfredo Castañeda-García; Antonio Oliver; Jesús Blázquez
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.